| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
serpin family A member 3 | 0.486 | 0.846 | 8.8E-14 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1990 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 2012 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 2012 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 2012 | 2019 | ||||||||
|
acyl-CoA thioesterase 7 | 0.531 | 0.769 | 0.76 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 1990 | 2020 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 1991 | 2020 | ||||||||
|
phosphodiesterase 4A | 0.523 | 0.846 | 0.98 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 1995 | 2019 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2012 | 2020 | ||||||||
|
actin beta like 2 | 0.539 | 0.769 | 5.8E-16 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 10 | 0.378 | 0.885 | 0.37 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2005 | 2019 | ||||||||
|
POTE ankyrin domain family member K, pseudogene | 0.542 | 0.769 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | |||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 2010 | 2020 | ||||||||
|
POTE ankyrin domain family member M | 0.541 | 0.769 | 3.2E-04 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
four and a half LIM domains 5 | 0.530 | 0.769 | 4.8E-10 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 2003 | 2019 | ||||||||
|
F2R like trypsin receptor 1 | 0.480 | 0.769 | 1.5E-04 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1999 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.600 | None | 0.875 | 14 | 0 | 2001 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.200 | None | 0.933 | 14 | 0 | 2005 | 2019 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.400 | None | 0.857 | 14 | 0 | 1995 | 2019 | ||||||||
|
C-C motif chemokine ligand 26 | 0.617 | 0.654 | 1.0E-02 |
|
disease | 0.300 | None | 1.000 | 13 | 0 | 2001 | 2019 | ||||||||
|
carboxyl ester lipase | 0.514 | 0.808 | 1.5E-06 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 1995 | 2020 | ||||||||
|
activator of HSP90 ATPase activity 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 2003 | 2019 | ||||||||
|
solute carrier family 27 member 5 | 0.563 | 0.769 | 8.4E-15 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 1995 | 2020 |